Limb-Girdle Muscular Dystrophy, Type 2E
Neurology·MeSH: Limb-girdle muscular dystrophy, type 2E
Prevalence
5.0 / 100K
2 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for Limb-Girdle Muscular Dystrophy, Type 2E?
BioSniper tracks 2 drugs in development for Limb-Girdle Muscular Dystrophy, Type 2E across 1 company.
How many clinical trials target Limb-Girdle Muscular Dystrophy, Type 2E?
There are 1 clinical trial targeting Limb-Girdle Muscular Dystrophy, Type 2E tracked by BioSniper.
What is the prevalence of Limb-Girdle Muscular Dystrophy, Type 2E?
The estimated prevalence of Limb-Girdle Muscular Dystrophy, Type 2E is approximately 5.0 per 100,000 population.
Deep-dive into Limb-Girdle Muscular Dystrophy, Type 2E
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis